KalVista Pharmaceuticals, Inc. , today provided its preliminary fourth quarter and full year ended December 31, 2025 unaudited global net product revenue results and other operational indicators. "We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback